Sulforaphane-Mediated Nrf2 Activation Prevents Radiation-Induced Skin Injury through Inhibiting the Oxidative-Stress-Activated DNA Damage and NLRP3 Inflammasome
- PMID: 34829721
- PMCID: PMC8614868
- DOI: 10.3390/antiox10111850
Sulforaphane-Mediated Nrf2 Activation Prevents Radiation-Induced Skin Injury through Inhibiting the Oxidative-Stress-Activated DNA Damage and NLRP3 Inflammasome
Abstract
This article mainly observed the protective effect of sulforaphane (SFN) on radiation-induced skin injury (RISI). In addition, we will discuss the mechanism of SFN's protection on RISI. The RISI model was established by the irradiation of the left thigh under intravenous anesthesia. Thirty-two C57/BL6 mice were randomly divided into control group (CON), SFN group, irradiation (IR) group, and IR plus SFN (IR/SFN) group. At eight weeks after irradiation, the morphological changes of mouse skin tissues were detected by H&E staining. Then, the oxidative stress and inflammatory response indexes in mouse skin tissues, as well as the expression of Nrf2 and its downstream antioxidant genes, were evaluated by ELISA, real-time PCR, and Western blotting. The H&E staining showed the hyperplasia of fibrous tissue in the mouse dermis and hypodermis of the IR group. Western blotting and ELISA results showed that the inflammasome of NLRP3, caspase-1, and IL-1β, as well as oxidative stress damage indicators ROS, 4-HNE, and 3-NT, in the skin tissues of mice in the IR group were significantly higher than those in the control group (p < 0.05). However, the above pathological changes declined sharply after SFN treatment (p < 0.05). In addition, the expressions of Nrf2 and its regulated antioxidant enzymes, including CAT and HO-1, were higher in the skin tissues of SFN and IR/SFN groups, but lower in the control and IR groups (p < 0.05). SFN may be able to suppress the oxidative stress by upregulating the expression and function of Nrf2, and subsequently inhibiting the activation of NLRP3 inflammasome and DNA damage, so as to prevent and alleviate the RISI.
Keywords: NLRP3; Nrf2; oxidative stress; radiation-induced skin injury; sulforaphane.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Protective effects of sulforaphane on diabetic retinopathy: activation of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation.Exp Anim. 2019 May 8;68(2):221-231. doi: 10.1538/expanim.18-0146. Epub 2019 Jan 1. Exp Anim. 2019. PMID: 30606939 Free PMC article.
-
Sulforaphane regulates Nrf2-mediated antioxidant activity and downregulates TGF-β1/Smad pathways to prevent radiation-induced muscle fibrosis.Life Sci. 2022 Dec 15;311(Pt B):121197. doi: 10.1016/j.lfs.2022.121197. Epub 2022 Nov 16. Life Sci. 2022. PMID: 36400201
-
Sulforaphane prevents bleomycin‑induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2‑related factor‑2 activation.Mol Med Rep. 2017 Jun;15(6):4005-4014. doi: 10.3892/mmr.2017.6546. Epub 2017 May 3. Mol Med Rep. 2017. PMID: 28487960 Free PMC article.
-
The Integrative Role of Sulforaphane in Preventing Inflammation, Oxidative Stress and Fatigue: A Review of a Potential Protective Phytochemical.Antioxidants (Basel). 2020 Jun 13;9(6):521. doi: 10.3390/antiox9060521. Antioxidants (Basel). 2020. PMID: 32545803 Free PMC article. Review.
-
Modulation of mitochondrial functions by the indirect antioxidant sulforaphane: a seemingly contradictory dual role and an integrative hypothesis.Free Radic Biol Med. 2013 Dec;65:1078-1089. doi: 10.1016/j.freeradbiomed.2013.08.182. Epub 2013 Aug 30. Free Radic Biol Med. 2013. PMID: 23999506 Review.
Cited by
-
The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?Antioxidants (Basel). 2024 Jan 2;13(1):70. doi: 10.3390/antiox13010070. Antioxidants (Basel). 2024. PMID: 38247494 Free PMC article. Review.
-
Rosmarinic Acid Inhibits Ultraviolet B-Mediated Oxidative Damage via the AKT/ERK-NRF2-GSH Pathway In Vitro and In Vivo.Biomol Ther (Seoul). 2024 Jan 1;32(1):84-93. doi: 10.4062/biomolther.2023.179. Biomol Ther (Seoul). 2024. PMID: 38148554 Free PMC article.
-
Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS).Cells. 2023 Dec 5;12(24):2773. doi: 10.3390/cells12242773. Cells. 2023. PMID: 38132093 Free PMC article.
-
Sulforaphane's Multifaceted Potential: From Neuroprotection to Anticancer Action.Molecules. 2023 Oct 1;28(19):6902. doi: 10.3390/molecules28196902. Molecules. 2023. PMID: 37836745 Free PMC article. Review.
-
Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase.J Transl Med. 2023 Oct 7;21(1):700. doi: 10.1186/s12967-023-04380-4. J Transl Med. 2023. PMID: 37805545 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
